60 degrees pharmaceuticals, Inc.(SXTP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SXTP 60 degrees pharmaceuticals, Inc.

Not Yet Opened 05-01 16:00:00 EDT

1.66

+0.08

+5.06%

盘后1.63

-0.03-1.81%

17:27 EDT

High1.70	Low1.57	Vol83.19K
Open1.57	D1 Closing1.58	Amplitude8.23%
Mkt Cap4.38M	Tradable Cap4.13M	Total Shares2.64M
T/O138.26K	T/O Rate3.34%	Tradable Shares2.49M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SXTP","market":"US","secType":"STK","nameCN":"60 degrees pharmaceuticals, Inc.","latestPrice":1.66,"timestamp":1777665600000,"preClose":1.58,"halted":0,"volume":83186,"hourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.66,"latestTime":"17:27 EDT","volume":619,"amount":1015.21,"timestamp":1777670863316,"change":-0.03,"changeRate":-0.018072,"amplitude":0.018072},"delay":0,"changeRate":0.050632911392404965,"floatShares":2490200,"shares":2636788,"eps":-11.729999,"marketStatus":"Not Yet Opened","change":0.08,"latestTime":"05-01 16:00:00 EDT","open":1.57,"high":1.7,"low":1.57,"amount":138259.8902392,"amplitude":0.082278,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.729999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":0,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":1.58,"preHourTrading":{"tag":"盘前","latestPrice":1.6177,"preClose":1.58,"latestTime":"08:20 EDT","volume":581,"amount":939.6176601,"timestamp":1777638036578,"change":0.0377,"changeRate":0.023861,"amplitude":0.01981},"postHourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.66,"latestTime":"17:27 EDT","volume":619,"amount":1015.21,"timestamp":1777670863316,"change":-0.03,"changeRate":-0.018072,"amplitude":0.018072},"volumeRatio":2.011547885026398},"requestUrl":"/m/hq/s/SXTP/wiki","defaultTab":"wiki","newsList":[{"id":"2629891811","title":"Analysts Are Bullish on Top Healthcare Stocks: IGC Pharma (IGC), 60 Degrees Pharmaceuticals, Inc. (SXTP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629891811","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629891811?lang=en_us&edition=fundamental","pubTime":"2026-04-24 17:00","pubTimestamp":1777021230,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IGC Pharma (IGC), 60 Degrees Pharmaceuticals, Inc. (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-igc-pharma-igc-60-degrees-pharmaceuticals-inc-sxtp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-igc-pharma-igc-60-degrees-pharmaceuticals-inc-sxtp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4112","BK4137","BK4104","BK4585","LU0029874061.USD","LU0128526141.USD","SXTP","BK4588","BLSG","IGC","LABU","XBI","BK4007","BLSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627828802","title":"60 Degrees Pharmaceuticals reports Arakoda availability on Runway Health website","url":"https://stock-news.laohu8.com/highlight/detail?id=2627828802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627828802?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:37","pubTimestamp":1776256627,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced Arakoda for malaria prevention is now available for purchase on the Runway Health website, for U.S. tra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-reports-arakoda-availability-on-runway-health-website-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-reports-arakoda-availability-on-runway-health-website-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627228124","title":"60 Degrees Pharma partners with Runway Health to sell ARAKODA online for travelers","url":"https://stock-news.laohu8.com/highlight/detail?id=2627228124","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627228124?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:05","pubTimestamp":1776254706,"startTime":"0","endTime":"0","summary":"60 Degrees Pharma added once-weekly malaria preventive ARAKODA  to Runway Health travel telehealth platform for online purchase.Runway Health clinicians will assess travelers for prescription eligibility, with delivery to U.S. customers before departure.Move expands ARAKODA access beyond traditional pharmacy channels, targeting U.S. travelers to malaria-endemic regions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief on April 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL6r19Q9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627028114","title":"60 Degrees Pharmaceuticals Inc - Pharma Announces Arakoda for Malaria Prevention Available on Runway Health Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2627028114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627028114?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:03","pubTimestamp":1776254623,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626518145","title":"60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2626518145","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626518145?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:53","pubTimestamp":1775735580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SXTP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 09, 2026 07:53 ET (11:53 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624501461","title":"60 Degrees Pharma CEO touts tafenoquine expansion push into babesiosis in Bloomberg TV interview","url":"https://stock-news.laohu8.com/highlight/detail?id=2624501461","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624501461?lang=en_us&edition=fundamental","pubTime":"2026-04-02 21:04","pubTimestamp":1775135071,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals CEO Geoffrey Dow outlined plans on Bloomberg TV to seek expanded FDA approval for antimalarial ARAKODA  to treat babesiosis.Management highlighted three ongoing clinical trials in babesiosis, including hospitalized patients.Tafenoquine holds Orphan Drug status for babesiosis, with patent exclusivity for malaria indication through 2035.Interview is scheduled to air April 4 at 7 p.m. ET on RedChip Small Stocks, Big Money.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL1SQ742:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623258047","title":"Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623258047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623258047?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:20","pubTimestamp":1774966808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXT...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-danaher-dhr-60-degrees-pharmaceuticals-inc-sxtp-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-danaher-dhr-60-degrees-pharmaceuticals-inc-sxtp-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930730.SGD","SXTP","LU2106854487.HKD","LU2023250504.SGD","IE000M9KFDE8.USD","LU2125909247.SGD","BK4504","LU0312595415.SGD","SG9999001176.USD","IE00BQXX3F31.USD","LU1023059063.AUD","LU0528227936.USD","LU1974910355.USD","LU2244417387.USD","LU2265009873.SGD","SGXZ57979304.SGD","SGXZ23171101.USD","LABU","LU0820562030.AUD","LU0289960550.SGD","BK4137","BK4585","IE00BQXX3D17.EUR","XLV","IE0004445239.USD","LU1366333091.USD","LU2125910336.SGD","LU0390134368.USD","LU0689472784.USD","IE00BQXX3C00.GBP","LU1057294990.SGD","LU0114720955.EUR","LU1791710400.SGD","LU0820561818.USD","LU1061106388.HKD","SG9999013999.USD","BK4007","LU0882574055.USD","LU0289961442.SGD","LU0672654240.SGD","SG9999001176.SGD","BK4139","LU0122379950.USD","BBIO","LU0029874061.USD","BK4121","DHR","XBI","HCSG","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623586698","title":"60 Degrees Q4 EPS $(1.47) Misses $(1.12) Estimate, Sales $303.385K Miss $400.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2623586698","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623586698?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:50","pubTimestamp":1774957839,"startTime":"0","endTime":"0","summary":"60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(1.47) per share which missed the analyst consensus estimate of $(1.12) by 31.25 percent. This is a 97.41 percent increase over losses of $(56.80) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51563428/60-degrees-q4-eps-1-47-misses-1-12-estimate-sales-303-385k-miss-400-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623458392","title":"Press Release: 60 Degrees Pharmaceuticals Announces 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2623458392","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623458392?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:01","pubTimestamp":1774954860,"startTime":"0","endTime":"0","summary":"-- FY 2025 net product revenues increased 65% to $1,005,000. -- Current shelf capacity exhausted after raise of $4 million through an ATM. WASHINGTON, March 31, 2026  -- 60 Degrees Pharmaceuticals, Inc.  , a pharmaceutical company focused on developing new medicines for vector-borne disease, reported today its financial results for the 2025 fiscal year ended December 31, 2025.-- Net product revenues increased 65% from $607.6 thousand in 2024 to $1.0. million in 2025, driven by rising sales, price increases, and fewer. -- The Company achieved a gross profit of approximately $223.8 thousand in. remained relatively stable despite inventory write-offs associated with a. final batch of short-dated product entering the supply chain. This charge. was a necessary, non-recurring cost incurred as part of scaling. -- Operating expenses were approximately $8.4 million in 2025, compared with. of non-cash and non-recurring charges. The increase in general and. $7.37 million, or $11.73 per share, com","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","R","BK4232","BK4007","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623245513","title":"60 Degrees Pharma FY25 operating loss narrows 16.24% to $8.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623245513","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623245513?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:32","pubTimestamp":1774906365,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals reported a net loss of $7.4 million for fiscal 2025.Gross margin fell 14.41 percentage points to 22.26%.Management projected cash runway through Sept. 30, 2026, assuming no additional capital raises.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL1qJVhV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621754131","title":"60 Degrees Updates Affiliate Share Ownership Disclosure Error","url":"https://stock-news.laohu8.com/highlight/detail?id=2621754131","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621754131?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:59","pubTimestamp":1774040351,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) has issued an update. On March 20, 2026, 60 Degrees Pharmaceuticals, Inc. reported that it had miscalc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-updates-affiliate-share-ownership-disclosure-error?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-updates-affiliate-share-ownership-disclosure-error?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621175195","title":"60 Degrees Pharmaceuticals corrects affiliate beneficial ownership to 23,367 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2621175195","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621175195?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:15","pubTimestamp":1774037758,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals issued a correction to a prospectus supplement after identifying an error in the reported common shares beneficially owned by a company affiliate.The affiliate’s beneficial ownership was revised to 23,367 shares from 21,490 shares.The company said the error originated from an incorrect total share amount in a Form 4 filed on September 15, 2025, which was carried forward into later filings.The corrected total beneficial ownership after the 1-for-4 reverse stock split was stated as 16,781 shares rather than 15,905 shares.It said no other information in the prospectus supplement was affected by the correction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL58SDhj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620253573","title":"BRIEF-60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract","url":"https://stock-news.laohu8.com/highlight/detail?id=2620253573","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620253573?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:06","pubTimestamp":1773835600,"startTime":"0","endTime":"0","summary":"BRIEF-60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut ExtractMarch 18 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN40615P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP","SXTPW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619214566","title":"60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2619214566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619214566?lang=en_us&edition=fundamental","pubTime":"2026-03-14 05:51","pubTimestamp":1773438707,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) has issued an update. On March 13, 2026, 60 Degrees Pharmaceuticals, Inc. filed an updated legal opini...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-updates-legal-opinion-for-atm-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-updates-legal-opinion-for-atm-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619906781","title":"What's Going On With 60 Degrees Pharmaceuticals On Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619906781","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619906781?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:11","pubTimestamp":1773407460,"startTime":"0","endTime":"0","summary":"60 Degrees Pharma shares fall premarket after a huge rally as its babesiosis trial reports a 100% cure rate with tafenoquine treatment.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/13/Pathway-Of-Infection.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/13/Pathway-Of-Infection.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51239146/whats-going-on-with-60-degrees-pharmaceuticals-on-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51239146/whats-going-on-with-60-degrees-pharmaceuticals-on-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618137401","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:55 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2618137401","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618137401?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:55","pubTimestamp":1773323756,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:55 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nAQN2LPYU2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618533941","title":"60 Degrees Pharmaceuticals reports 100% babesiosis cure rate in tafenoquine expanded access trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2618533941","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618533941?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:24","pubTimestamp":1773228265,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals reports 100% babesiosis cure rate in tafenoquine expanded access trial               60 Degrees Pharmaceuticals reported that all three enrolled patients in its open-label e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL46ST3m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","NDAQ","BK4585","SG9999014005.SGD","BK4007","LU0314104364.USD","SG9999014021.USD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","IE00BGHQF748.EUR","SXTP","LU2210150020.SGD","LU2095319765.USD","BK4588","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618294130","title":"60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2618294130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618294130?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:24","pubTimestamp":1773228240,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nTUA3LWNBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTPW","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610220789","title":"BRIEF-60 Degrees Pharmaceuticals Company Regained Compliance With Nasdaq Minimum Bid Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2610220789","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610220789?lang=en_us&edition=fundamental","pubTime":"2026-02-12 22:32","pubTimestamp":1770906749,"startTime":"0","endTime":"0","summary":"BRIEF-60 Degrees Pharmaceuticals Company Regained Compliance With Nasdaq Minimum Bid Price Feb 12  - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACEUTICALS INC - COMPANY REGAINED COMPLIANCE WITH NASDAQ MINIMUM BID PRICE - SEC FILINGSource text: [ID:n0001213900-26-015239]Further company coverage: SXTP.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nFWN3Z81H1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610392217","title":"60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2610392217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610392217?lang=en_us&edition=fundamental","pubTime":"2026-02-12 22:17","pubTimestamp":1770905851,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) just unveiled an update. On January 20, 2026, 60 Degrees Pharmaceuticals received notice from Nasdaq t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-regains-nasdaq-listing-compliance-status?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-regains-nasdaq-listing-compliance-status?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP","NQmain"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.60degreespharma.com","stockEarnings":[{"period":"1week","weight":0.0184},{"period":"1month","weight":-0.1123},{"period":"3month","weight":-0.6},{"period":"6month","weight":-0.6949},{"period":"1year","weight":-0.8327},{"period":"ytd","weight":-0.1836}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is based in Washington, District Of Columbia.","exchange":"NASDAQ","name":"60 degrees pharmaceuticals, Inc.","nameEN":"60 degrees pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"60 degrees pharmaceuticals, Inc.(SXTP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 60 degrees pharmaceuticals, Inc.(SXTP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"60 degrees pharmaceuticals, Inc.,SXTP,60 degrees pharmaceuticals, Inc.股票,60 degrees pharmaceuticals, Inc.股票老虎,60 degrees pharmaceuticals, Inc.股票老虎国际,60 degrees pharmaceuticals, Inc.行情,60 degrees pharmaceuticals, Inc.股票行情,60 degrees pharmaceuticals, Inc.股价,60 degrees pharmaceuticals, Inc.股市,60 degrees pharmaceuticals, Inc.股票价格,60 degrees pharmaceuticals, Inc.股票交易,60 degrees pharmaceuticals, Inc.股票购买,60 degrees pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"60 degrees pharmaceuticals, Inc.(SXTP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 60 degrees pharmaceuticals, Inc.(SXTP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction